Chordate Medical
"The treatment makes a big difference for me" – New article in Svenska Dagbladet about Ozilia from Chordate
Svenska Dagbladet highlights Chordate Medical’s migraine treatment Ozilia in a new feature – and meets one of the first Swedes to try the method.
In the article, Margareta Hoas shares her story of a life marked by chronic migraines, numerous failed treatment attempts and medications, and how Ozilia has finally provided her with noticeable relief.
“It makes a big difference for me. It brings the pain down two notches on the scale and makes life more bearable,” she tells the newspaper.
Migraine expert Lars Edvinsson, Professor of Internal Medicine at Lund University, also sees potential in the method as a possible complement to established CGRP inhibitors – medications currently used to prevent migraine attacks but which don’t work for everyone.
“These [CGRP inhibitors] have helped a large portion of those suffering from migraines. But there is still a group of patients that does not respond to the treatment. If the results hold up, the [Ozilia] method could function as a complement to already established CGRP inhibitor treatments,” he tells Svenska Dagbladet.
Read the full article (In Swedish)
| Datum | 2025-04-03, kl 10:20 |
| Källa | MFN |
100% cashback på aktiecourtage! Handla aktier på eToro och få tillbaka 100% av ditt courtage i 3 månader. Hur? Registrera dig här nu direkt för att ta del av erbjudandet.